Clincosm LogoSign in Get a demo

Prostate Adenocarcinoma

Showing NaN - NaN of 15
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in Houston (Abiraterone Acetate, Bicalutamide, Degarelix)

Active, not recruiting
  • Prostate Adenocarcinoma
  • Recurrent Prostate Carcinoma
  • Abiraterone Acetate
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Male Erectile Disorder, Prostate Adenocarcinoma, Erectile Dysfunction, CTCAE Trial in Houston (Atorvastatin, Pentoxifylline,

Completed
  • Male Erectile Disorder
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 21, 2022

Prostate Adenocarcinoma, PSA Level Greater Than Ten, Stage IIB Prostate Cancer AJCC v8 Trial in Houston (Hyperpolarized Carbon C

Active, not recruiting
  • Prostate Adenocarcinoma
  • +9 more
  • Hyperpolarized Carbon C 13 Pyruvate
  • Magnetic Resonance Spectroscopic Imaging
  • Houston, Texas
    M D Anderson Cancer Center
Nov 16, 2022

Quantitative HP MRI for Clinical Prostate Cancer Exam

Active, not recruiting
  • Prostate Adenocarcinoma
  • Hyperpolarized Carbon C 13 Pyruvate
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 16, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Prostate Adenocarcinoma Trial in Houston

Completed
Has Results
  • Castration-Resistant Prostate Carcinoma
  • +5 more
  • Durvalumab
  • Tremelimumab
  • Houston, Texas
    M D Anderson Cancer Center
Nov 9, 2022

Metastatic Prostate Cancer, Prostate Adenocarcinoma Trial in Worldwide (Cabozantinib, Atezolizumab, Abiraterone Acetate)

Recruiting
  • Metastatic Prostate Cancer
  • Prostate Adenocarcinoma
  • Tucson, Arizona
  • +259 more
Oct 19, 2022

Metastatic Prostate Carcinoma, Prostate Adenocarcinoma, Prostate Carcinoma Metastatic in the Bone Trial in Houston (Abiraterone

Active, not recruiting
  • Metastatic Prostate Carcinoma
  • +5 more
  • Abiraterone Acetate
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 26, 2022

Prostate Adenocarcinoma, Stage IIB Prostate Cancer AJCC v8, Stage IIC Prostate Cancer AJCC v8 Trial in Houston (drug,

Completed
Has Results
  • Prostate Adenocarcinoma
  • +4 more
  • Abiraterone Acetate
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 14, 2022

Biochemically Recurrent Prostate Carcinoma, Localized Prostate Carcinoma, Prostate Adenocarcinoma Trial in Houston (Fluorine F

Recruiting
  • Biochemically Recurrent Prostate Carcinoma
  • +2 more
  • Fluorine F 18 rhPSMA-7.3
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 31, 2022

Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8, Stage IIIA Prostate Cancer AJCC v8 Trial in Houston (biological,

Active, not recruiting
  • Prostate Adenocarcinoma
  • +5 more
  • Daratumumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 25, 2022

Prostate Adenocarcinoma, Prostate Carcinoma Trial in Houston (Magnetic Resonance Imaging)

Recruiting
  • Prostate Adenocarcinoma
  • Prostate Carcinoma
  • Magnetic Resonance Imaging
  • Houston, Texas
    M D Anderson Cancer Center
Nov 22, 2021

Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8 Trial in Houston (Dietary

Recruiting
  • Prostate Adenocarcinoma
  • +6 more
  • Dietary Intervention
  • Radical Prostatectomy
  • Houston, Texas
    M D Anderson Cancer Center
Aug 31, 2021

Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Lymphadenopathy Trial in Detroit, Houston

Completed
Has Results
  • Castration Levels of Testosterone
  • +6 more
  • Detroit, Michigan
  • +1 more
Jul 29, 2021

Prostate Adenocarcinoma, Stage IIA Prostate Cancer AJCC v7, Stage IIB Prostate Cancer AJCC v7 Trial in United States (Goserelin

Terminated
Has Results
  • Prostate Adenocarcinoma
  • +2 more
  • Goserelin Acetate
  • +3 more
  • Ann Arbor, Michigan
  • +4 more
Feb 6, 2019

Prostate Adenocarcinoma, Stage I Prostate Cancer, Stage IIA Prostate Cancer Trial in United States (drug, other, procedure)

Completed
Has Results
  • Prostate Adenocarcinoma
  • +4 more
  • Los Angeles, California
  • +14 more
Sep 18, 2017